13Gérard Siest
Summary for 2003 [at-glance overview of Gérard Siest work for the selected year as suggested by data mining algorithms]
This is an Authoratory overview of author Gérard Siest. According to available data, in 2003 Gérard Siest published at least 13 articles. This work was completed in collaboration with several authors including Visvikis, Sophie and Sass, Catherine. Many other authors have collaborated with Gérard Siest as well. There is no information about the funding or the grants awarded to support this work.
Gérard Siest has rank 10 when compared to all other authors using the keyword Lipids. Analysis of the article abstracts and the titles suggests that Gérard Siest professional interests are focused around "serum apoc-iii concentration", "polymorphism confidence interval" and "phenotype genotype assessments". These might also be referred to as "stanislas cohort", "apoc-iii concentration" or "g-463a polymorphism". Statistical analysis shows that Gérard Siest's writing is likely to contains terms "polymorphism", "mpo", "study", "serum", "paraoxonase" and "stanislas".
The affiliations of Gérard Siest vary, with National Research Center Centre for Preventive Medicine, 10, Petroverigsky street, 101953 Moscow, Russia being the most prominent. Luckily, several email addresses are on file.
| ENFRESRU |   | make correctionleave commentask question |
Images [images we found on the Internet for Gérard Siest]
Do you know Gérard Siest who matches the profile above? Click the photo and let us know!Alternative names (1) [other authors with names similar to Gérard Siest]
Science Trivia (2) [Interactive math & science trivia questions]
Year 2003 Charts [Gérard Siest frequent coauthors and the most common unique vocabulary terms for the selected year]
Historical Performance Charts [graphical overview of Gérard Siest publication and funding history for the range of years]
Emails (2) [email addresses extracted from Gérard Siest affiliations]
hidden to prevent spam, click here to reveal
Other [context-specific ads]
Affiliations (10) [condensed summary of the Gérard Siest affiliations, the leading number and the color conveys importance]
- 3National Research Center Centre for Preventive Medicine, 10, Petroverigsky street, 101953 Moscow, Russia.
2INSERM U-525, Centre de Médecine Préventive, Preventive, Vandoeuvre-Les-Nancy, France.
1INSERM Unité 525, Centre de Médecine Préventive and Faculté de Pharmacie, Nancy, France.
1INSERM Unite 525 equipe 4, Centre de Médecine Préventive, 2, avenue du Doyen Jacques Parisot, 54501 Vandoeuvre-lès-Nancy, France.
1INSERM U525, Paris, France. INSERM U525, Nancy, France.
1INSERM U525 and Centre de Médecine Préventive, 2 avenue Jacques Parisot, F-54500 Vandoeuvre-lès-Nancy, France.
1Laboratoire du Centre de Médecine Préventive and Unité INSERM 525, Vandoeuvre-lès-Nancy, France.
1INSERM U 525, Centre du Médicament, Faculté de Pharmacie, Université Henri Poincaré Nancy I, Nancy, France.
1Inserm Unité 525 équipe 4, Centre de Médecine Préventive, 2 avenue du Doyen Jacques Parisot, 54501 Vandoeuvre-Les-Nancy, Nancy, France.
1Institut National de Santé et de Recherche Médicale U525, Centre de Médecine Préventive, 2 Avenue du Doyen J. Parisot, F54500 Vandoeuvre-Lès-Nancy, France.
Key Opinion Leader In [Gérard Siest is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]
- 10Lipids | 13Apolipoproteins E | 24France | 45Cholesterol, HDL | 59Polymorphism, Genetic | 75Triglycerides | 83Cohort Studies | 240Genotype | 693Adolescent
Keywords (32) [keywords assigned to Gérard Siest articles by PubMed, the leading number and the color conveys importance]
- 12Humans | 9Male | 8Female | 7Adult | 6Cohort Studies | 6Polymorphism, Genetic | 5Adolescent | 5Middle Aged | 5France | 4Apolipoproteins E | 4Child | 4Genotype | 4Lipids | 3Triglycerides | 3Cholesterol, HDL | 3Child, Preschool | 3Aged | 3Risk Factors | 2Phenotype | 2Cholesterol | 2Peroxidase | 2Antioxidants | 2Reference Values | 2Aryldialkylphosphatase | 2Genetic Predisposition to Disease | 2Smoking | 2Polymerase Chain Reaction | 1Inflammation Mediators | 1Hyperlipoproteinemia Type II | 1Glutathione Peroxidase | 1Sodium Chloride | 1Intercellular Adhesion Molecule-1
Gérard Siest Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Gérard Siest might be a good expert witness on these terms]
- 17polymorphism | 16mpo | 16study | 15serum | 14paraoxonase | 13stanislas | 13cohort | 12factors | 11polymorphisms | 11risk | 11apoe | 11allele | 10association | 10apoc-iii | 10cardiovascular | 10vitamin | 9apolipoprotein | 9lipoproteins | 9associated | 9height | 9subjects | 9concentration | 8activities | 8patients | 8genetic | 7reference | 7drugs | 7ad | 7alcohol | 7aging | 6functional | 6myeloperoxidase
- 13stanislas cohort | 8apoc-iii concentration | 6g-463a polymorphism | 6serum apoc-iii | 5risk factors | 4mpo polymorphisms | 4cardiovascular risk | 4salt-stimulated paraoxonase | 4polymorphism confidence | 4confidence interval | 4genotype assessments | 4pon1-192 phenotype | 4paraoxonase arylesterase | 4basal paraoxonase | 4reference limits | 3glutathione peroxidase | 3functional outcome | 3exchangeable apolipoproteins | 3subjects stanislas | 3height cardiovascular | 3allele g-463a | 3zinc selenium | 3slow h-components | 3apoe phenotype | 3oral contraceptive | 3factors reference | 3aging indicator | 3phenotype genotype | 3reference intervals | 3lipoprotein lipase | 3apoeurope study | 3placebo group
- 5serum apoc-iii concentration | 4polymorphism confidence interval | 3phenotype genotype assessments | 3oral contraceptive intake | 3stanislas cohort study | 3cardiovascular risk factors | 3allele g-129a polymorphism | 3subjects stanislas cohort | 3height cardiovascular risk | 3allele g-463a polymorphism | 2apolipoproteins solution lipid-bound | 2effect six candidate | 2lipoproteins hypertriglyceridemia capillary | 2disease apoeurope study | 2time-dependent lipid response | 2hypercholesterolemia sensitive apoe | 2candidate genes early | 2infarct size functional | 2pon1-192 phenotype genotype | 2solution lipid-bound form | 2fluvastatin therapy patients | 2human plasma lipoproteins | 2pharmacogenomics drugs affecting | 2g-129a polymorphism confidence | 2early aging french | 2patients hypercholesterolemia sensitive | 2peroxidase activities stanislas | 2aging french population | 2cohort influencing factors | 2polymorphism alzheimer disease | 2superoxide dismutase whole-blood | 2paraoxonase salt-stimulated paraoxonase
Reader's Comments (0) [comments posted by readers of Gérard Siest profile]
no comments yet
Funding (0) [selected NIH grants to Gérard Siest and the award amounts for recent years]
- award information is not available
Gérard Siest Articles (13) [selected PubMed articles for the year 2003 with the links to a full text at PubMed]
Time-dependent lipid response on fluvastatin therapy of patients with hypercholesterolemia sensitive to apoE phenotype. (2003) >>
National Research Centre for Preventive Medicine, 10, Petroverigsky Street, 101953 Moscow, Russia.
3Dergunov, Alexander D, 16Visvikis, Sophie, , 13Siest, Gérard.Myeloperoxidase G-463A polymorphism and Alzheimer's disease in the ApoEurope study. (2003) >>
INSERM Unité 525, Centre de Médecine Préventive and Faculté de Pharmacie, Nancy, France.
, 2Pfister, Michèle, , 16Visvikis, Sophie, , , , 2Leininger-Muller, Brigitte, 5Herbeth, Bernard, 13Siest, Gérard.IL-6, TNF-alpha and atherosclerosis risk indicators in a healthy family population: the STANISLAS cohort. (2003) >>
INSERM Unite 525 equipe 4, Centre de Médecine Préventive, 2, avenue du Doyen Jacques Parisot, 54501 Vandoeuvre-lès-Nancy, France.
, 3Lambert, Daniel, 3Zaiou, Mohamed, 16Visvikis, Sophie, 4Sass, Catherine, , 1Haddy, Nadia, 13Siest, Gérard.Family study of the relationship between height and cardiovascular risk factors in the STANISLAS cohort. (2003) >>
INSERM U525, Paris, France. INSERM U525, Nancy, France.
16Visvikis, Sophie, 2Trégouët, David-Alexandre, 10Tiret, Laurence, 4Sass, Catherine, 13Siest, Gérard, .Changes in serum retinol, alpha-tocopherol, vitamin C, carotenoids, xinc and selenium after micronutrient supplementation during alcohol rehabilitation. (2003) >>
INSERM U525 and Centre de Médecine Préventive, 2 avenue Jacques Parisot, F-54500 Vandoeuvre-lès-Nancy, France.
3Leroy, Pierre, , 16Visvikis, Sophie, , 7Hercberg, Serge, 3Arnaud, Josiane, , 5Herbeth, Bernard, 2Guilland, Jean-Claude, 13Siest, Gérard.Charge-based heterogeneity of human plasma lipoproteins at hypertriglyceridemia: capillary isotachophoresis study. (2003) >>
National Research Centre for Preventive Medicine, 10, Petroverigsky street, 101953, Moscow, Russia.
, 3Dergunov, Alexander D, , 16Visvikis, Sophie, 13Siest, Gérard.PON1-192 phenotype and genotype assessments in 918 subjects of the Stanislas cohort study. (2003) >>
INSERM U-525, Centre de Médecine Préventive, Vandoeuvre-Les-Nancy, France.
, 4Vincent-Viry, Monique, 16Visvikis, Sophie, , 4Sass, Catherine, 13Siest, Gérard.Effect of six candidate genes on early aging in a French population. (2003) >>
Laboratoire du Centre de Médecine Préventive and Unité INSERM 525, Vandoeuvre-lès-Nancy, France.
4Vincent-Viry, Monique, 16Visvikis, Sophie, 2Guéguen, René, 1Xia, Yongjing, 13Siest, Gérard.Pharmacogenomics of drugs affecting the cardiovascular system. (2003) >>
INSERM U 525, Centre du Médicament, Faculté de Pharmacie, Université Henri Poincaré Nancy I, Nancy, France.
16Visvikis, Sophie, 1Batt, Anne-Marie, 1Ferrari, Luc, , 13Siest, Gérard.Myeloperoxidase polymorphisms in brain infarction. Association with infarct size and functional outcome. (2003) >>
Inserm Unité 525 équipe 4, Centre de Médecine Préventive, 2 avenue du Doyen Jacques Parisot, 54501 Vandoeuvre-Les-Nancy, Nancy, France.
7Poirier, Odette, , 16Visvikis, Sophie, , 4Elbaz, Alexis, 2Leininger-Muller, Brigitte, 5Amarenco, Pierre, 13Siest, Gérard.Homo- and hetero-complexes of exchangeable apolipoproteins in solution and in lipid-bound form. (2003) >>
National Research Center for Preventive Medicine, 10, Petroverigsky street, 101953 Moscow, Russia.
3Dergunov, Alexander D, 16Visvikis, Sophie, , 13Siest, Gérard.Biological and genetic determinants of serum apoC-III concentration: reference limits from the Stanislas Cohort. (2003) >>
Institut National de Santé et de Recherche Médicale U525, Centre de Médecine Préventive, 2 Avenue du Doyen J. Parisot, F54500 Vandoeuvre-Lès-Nancy, France.
4Vincent-Viry, Monique, 16Visvikis, Sophie, , , 4Sass, Catherine, 13Siest, Gérard.Serum total antioxidant status, erythrocyte superoxide dismutase and whole-blood glutathione peroxidase activities in the Stanislas cohort: influencing factors and reference intervals. (2003) >>
INSERM U-525, Centre de Médecine Preventive, Vandoeuvre-Les-Nancy, France.
, 4Vincent-Viry, Monique, 1Lamont, John V, 16Visvikis, Sophie, , 5Herbeth, Bernard, 13Siest, Gérard.
The content of this page was generated automatically by a computer program.
Copyright © 2006-2009 Authoratory.com | All rights reserved | Terms of use | Privacy policy